Estrogen Therapy and Risk of Cardiovascular Events Among Women With Type 2 Diabetes (Q79091184)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Estrogen therapy and risk of cardiovascular events among women with type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Estrogen Therapy and Risk of Cardiovascular Events Among Women With Type 2 Diabetes (English)

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

15 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

15 March 2024

3

Susan R Heckbert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

2

Andrea Z LaCroix

Andrea Z. LaCroix

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14514584

15 March 2024

1

Katherine M Newton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Linn Abraham

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

David McCulloch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

William Barlow

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

0 references

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

published in

Diabetes Care

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

2810-2816

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up

19 December 2019

cites work

1

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

15 March 2024

2

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women

15 March 2024

3

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

15 March 2024

4

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

15 March 2024

5

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.

15 March 2024

6

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Postmenopausal estrogens and risk of myocardial infarction in diabetic women

15 March 2024

7

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study

15 March 2024

8

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Selecting an efficient design for assessing exposure-disease relationships in an assembled cohort

15 March 2024

9

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Women's beliefs and decisions about hormone replacement therapy

15 March 2024

10

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

15 March 2024

11

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

A chronic disease score with empirically derived weights

15 March 2024

12

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Analysis of case-cohort designs

15 March 2024

13

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Robust variance estimation for the case-cohort design.

15 March 2024

14

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women

15 March 2024

16

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study

15 March 2024

17

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

15 March 2024

18

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Estrogen replacement therapy and prognosis after first myocardial infarction

15 March 2024

19

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

15 March 2024

20

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy

15 March 2024

21

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Cross-cultural perspectives on menopause

15 March 2024

22

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM

15 March 2024

24

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

The effect of hormone replacement therapy on cardiovascular risk factors in type 2 diabetes: a randomized controlled trial

15 March 2024

25

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions

15 March 2024

26

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Effect of hormone replacement therapy on insulin secretion and insulin sensitivity in postmenopausal diabetic women

15 March 2024

27

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy

15 March 2024

28

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry

15 March 2024

29

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III).

15 March 2024

30

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus

15 March 2024

31

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

15 March 2024

32

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Hormone replacement therapy and glucose metabolism.

15 March 2024

33

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

Sex differences in fasting glycemia as a risk factor for ischemic heart disease death

15 March 2024

34

1 reference

https://api.crossref.org/works/10.2337/DIACARE.26.10.2810

15 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14514584%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference